CochLear (OTCMKTS:CHEOY) Rating Increased to Strong-Buy at UBS Group

CochLear (OTCMKTS:CHEOY) was upgraded by UBS Group from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Wednesday,Zacks.com reports.

CochLear Stock Performance

CochLear stock opened at $92.38 on Wednesday. CochLear has a 12 month low of $74.76 and a 12 month high of $115.85. The business has a 50 day simple moving average of $86.82 and a 200-day simple moving average of $88.73.

About CochLear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.